Health Secretary Robert F. Kennedy Jr. is campaigning across the country to promote the Trump administration's "MAHA" agenda, consistently avoiding discussions of vaccine policy.
The White House strategy is deliberate: use Kennedy as a midterm asset while keeping him focused on other MAHA policy wins and away from the unpopular vaccine changes the administration wants to pursue.
Kennedy attributed declining vaccination rates to the COVID-19 pandemic. "During COVID, people lost faith in the public health system," he said. "My job is to make the public health establishment trustworthy."
Before joining the administration, Kennedy was a prominent anti-vaccine activist and has long opposed vaccine requirements. President Trump has signaled intent to alter federal vaccine guidelines through executive order, but Kennedy-backed efforts to reduce recommended vaccinations have been blocked by the courts.
The maneuvering has created tension among Kennedy's most devoted followers. Some view his current posture as a betrayal, arguing he has not gone far enough to dismantle the country's vaccine framework. They contend he erred by "leaving too much of the edifice standing" rather than taking a more aggressive stance.
For the White House, the calculus is straightforward: Kennedy's value in midterm politics depends on emphasizing policy wins that resonate with voters, not relitigating vaccine fights the administration cannot currently win in court.
